Tran, Dan N.Njuguna, BensonMercer, TimothyManji, ImranFischer, LydiaLieberman, MaryaPastakia, Sonak2023-10-102023-10-102017Tran DN, Njuguna B, Mercer T, et al. Ensuring Patient-Centered Access to Cardiovascular Disease Medicines in Low-Income and Middle-Income Countries Through Health-System Strengthening. Cardiol Clin. 2017;35(1):125-134. doi:10.1016/j.ccl.2016.08.008https://hdl.handle.net/1805/36245Cardiovascular disease (CVD) is the leading cause of global mortality and is expected to reach 23 million deaths by 2030. 80% of CVD deaths occur in low- and middle- income countries (LMICs). Although CVD prevention and treatment guidelines are available, translating these into practice is hampered in LMICs by inadequate healthcare systems which limit access to lifesaving medications. In this review article, we describe the deficiencies in the current LMIC supply chains that limit access to effective CVD medicines, and discuss existing solutions that are translatable to similar settings in order to address these deficiencies.en-USPublisher PolicyPatient-centered accessCardiovascular disease medicinesAvailabilityAccountabilityAdherenceHealth-system strengtheningLow- and middle-income countriesFalsified and substandard medicinesArticle